What does the 2-year follow-up tell us about the use of pembrolizumab for advanced bladder cancer?
Robert Jones • 8 Feb 2018
EMT switch activation by peri-neural invading epithelial cells decreases OS in prostate cancer
Noel Clarke • 16 Jul 2021
TRISST: MRI versus FDG-PET-CT for the treatment of testicular cancer
Tahlita Zuiverloon • 15 Jul 2021